NRAS and melanoma: To validate the 18 candidate regulators of the molecular networks underlying primary melanoma prognosis, we performed siRNA knockdown experiments in SKmel147 (NRAS mutant) and A375 (BRAF mutant) cell lines (see siRNA screening of candidate targets in Supplementary Methods).